What to know about Sinovac’s corona virus vaccine CoronaVac
Turkey has announced Phase-3 results of the corona virus vaccine developed by Chinese biopharmaceutical company Sinovac. Hacettepe University announced the effectiveness of the coronavac vaccine as 83.5 percent. The rate at which the vaccine prevents hospitalization was 100 percent.
However, as the race to produce a global Covid-19 vaccine continues between Pfizer/BionTech, Moderna, AstraZeneca/Oxford, Gamaleya Institute and many more companies, Sinovac, one of China’s vaccine pioneers, appears to be making big strides. So, “what is the difference between the Sinovac vaccine and other vaccines?”, “What are the side effects of the Chinese vaccine?”“How effective is the vaccine?, “Will the corona virus vaccine be free? “and “how will the vaccine be stored?”you can find answers to all questions that are curious with CoronaVac, such as in our news.
Phase-3 results of the Coronavac vaccine from Sinovac in Turkey were announced. According to Hacettepe University Phase 3 results, the effectiveness of the Sinovac vaccine was announced as 83.5 percent. The rate of blocking hospitalization of the vaccine was found to be 100 percent.
WHAT ARE THE MOST COMMON SIDE EFFECTS OF THE SINOVAC VACCINE?
In the statement, the most common side effects after the vaccine were also included. Fatigue (9.8 percent), Head weight (7.6 percent) muscle pain (3.8 percent) fever (2.5 percent) chills (2.4 percent) and pain at the injection site were the most common local side effects Nov. The vaccine began to be administered in Turkey on January 14.
Stage 3 clinical trials began in Brazil on July 21 and Indonesia on August 11 for the vaccine candidate, whose formula contains an inactivated version of the virus. Along with 1.8 million doses, it has reached Indonesia in preparation for a mass vaccination campaign.
FIRST COVID-19 VACCINE TESTED IN TURKEY
In addition, Coronavac, which began to be tested on humans on September 17 as part of the 3rd stage trials, was the “first Covid-19 vaccine tested in Turkey”. Experiments conducted on 13 thousand people in 25 centers began with health workers. In November, other than health workers, hearts were included in the study.
WHAT IS THE DIFFERENCE BETWEEN SINOVAC AND OTHER VACCINES?
CoronaVac is an inactivated vaccine that works by using killed viral particles to expose the body’s immune system to the virus without the risk of a serious disease response. Pfizer/BioNTech and Moderna vaccines, which are described as 95 percent and 94 percent effective, respectively, were developed using the Mrna method. These vaccines work by injecting part of the genetic code of the corona virus into the body, which in turn triggers the body to start producing antibodies.
Associate professor at Nanyang Technological University located in Singapore. Dr. “CoronaVac is a more traditional vaccine method that has been successfully used in many well-known vaccines, such as rabies,” Luo Dahai told the BBC. mRNA vaccines are a new type of vaccine, and there is no successful example that has been used in the community so far,” he said.
STORAGE CONDITIONS ARE MORE ADVANTAGEOUS
One of the main advantages of Sinovac is that it can be stored at 2-8 degrees Celsius in a standard refrigerator, such as the Oxford/AstraZeneca vaccine, made from a genetically engineered virus that causes colds in chimpanzees. Experts note that the Moderna vaccine is much easier to distribute than the Prizer/BioNTech vaccine, but the Sinovac and AstraZenaca/Oxford vaccines all have the most advantageous storage and transportation conditions.